PrescQIPP in brief

We are an NHS funded not-for-profit organisation that supports quality, optimised prescribing for patients. We produce evidence-based resources and tools for primary care commissioners, and provide a platform to share innovation across the NHS. Most of our materials are publicly available, however we also provide a range of data and intelligence toolswebinars and events for our subscribers. We also aim to engage with a broad range of stakeholders including patients and carer groups, the pharmaceutical industry and voluntary sector organisations.

You can read more about us and answers to some of our most frequently asked questions.

Latest news stories

Bulletin 135 - Antipsychotics update

This Antipsychotics bulletin and resources have been updated to include cost effective choices of modified release quetiapine products (for those organisations wishing to use branded generic prescribing). There are two briefings and datapacks to support this bulletin. One is for switching from quetiapine XL to quetiapine immediate release (IR) or cost effective branded products where applicable, and the other a general one which focuses on making local prescribing choices and also includes advice on switching from olanzapine lyophilisates tablets to orodispersible tablets and risperidone orodispersible to standard risperidone tablets as appropriate.

Info_bulletin_SQ.png  Antipsychotic drugs 

Bulletin 132 Fentanyl (DROP-List) now available to all PrescQIPP users

Fentanyl (DROP-List) is now available to all PrescQIPP users.

Immediate release fentanyl has a NICE do not do as a first line treatment for breakthrough pain. This bulletin which is a DROP list support bulletin will focus on fentanyl immediate-release formulations and provide the rationale for new patients to be commenced on immediate-release morphine, and for current patients to be considered for a switch to immediate-release morphine or have their therapy reviewed and stopped where appropriate. An audit and patient letters are available as supporting resources.

Info_bulletin_SQ.png  Fentanyl

Bulletin 131 Wound care: Topical negative pressure therapy now available to all PrescQIPP users

Wound care: Topical negative pressure therapy is now available to all PrescQIPP users.

Negative pressure wound therapy (NPWT) is increasingly being used as a treatment option for acute, chronic and surgical wounds, and is also being used within community environments. This bulletin will review its place in therapy and focus on ensuring that NPWT is used appropriately, and with minimal wastage.

Info_bulletin_SQ.png   Wound care - Negative pressure wound therapy

Bulletin 136 Ensuring Appropriate Polypharmacy now available to all PrescQIPP users

Ensuring Appropriate Polypharmacy is now available to all PrescQIPP users.

The second of our polypharmacy and deprescribing bulletins - Ensuring Appropriate Polypharmacy. This bulletin covers a strategic overview of polypharmacy and deprescribing and also has more detailed information and tools to support medication review. 

The accompanying Ensuring Appropriate Polypharmacy Tool (flowchart) will be the overarching tool that underpins al our polypharmacy and deprescribing resources.

 Polypharmacy - Ensuring Appropriate Polypharmacy

You can also view this amongst the wider range of Polypharmacy materials in the Polypharmacy and Deprescribing Webkit.

Bulletin 125 Tiotropium in asthma now available to all PrescQIPP users

Tiotropium in asthma is now available to all PrescQIPP users.

This resource looks at the place in therapy for tiotropium in asthma and compares to other treatments on the same step of the BTS guidelines. An educational slideset is available as a supporting tool for practice staff training.

  Tiotropium in asthma

Bulletin 124 Managed repeats and implementing repeat prescribing now available to all PrescQIPP users

Managed repeats and implementing repeat prescribing is now available to all PrescQIPP users.

This bulletin focuses on repeat dispensing, repeat prescribing, EPS and repeat prescription ordering services. Template training packs for practice staff and patient information letters are available as supporting resources.

  Repeat prescriptions

Horizon scan

This table shows the most recent PrescQIPP publications and the resources currently passing through our quality assurance process. Items marked 'coming soon' or 'in QA'  are yet to go out to stakeholder consultation. To register your interest to feed in to the development of our resources, please visit our stakeholder page or email our Operations Manager, Michelle Harrison:

View our 2016/17 work plan

Please note the work plan is subject to change throughout the year due to subscriber input.

What's on the PrescQIPP Twitterista

Just one month left until our innovation awards deadline -
Oh we've also published Bulletin 140 Launched - Anticholinergic drugs - for our subscribers
Whoa! Our website seems to have just passed a million hits! How did that happen!?!
Cheers @elizbeech we're v excited about where we're going to take this fancy platform. @Jon_BristolNHS shout if you'd like a preview.
PrescQIPP's July newsletter -
Follow PrescQIPP CIC on Twitter